Abstract
After a lengthy search for an effective treatment for resected pancreatic cancer, evidence accumulated in the past 10 years shows that adjuvant chemotherapy is firmly established as offering a modest but real improvement in overall survival. However, the optimal choice of treatment modality (chemotherapy with or without radiation therapy) remains highly controversial. Results from ongoing studies will further optimize the treatment over the next decade.
Full Text
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call